Fresh waves of violence have erupted across Bangladesh, as the Bangladesh student protests intensify amid demands for justice and systemic reform. The unrest, which initially started in the north-eastern city of Sylhet, has rapidly spread to the capital Dhaka and other major cities, marking a significant escalation in the ongoing crisis. The demonstrations have become […]
Shell Deutschland GmbH has made a pivotal move in advancing renewable energy with its Final Investment Decision (FID) to proceed with the REFHYNE II PEM hydrogen electrolyser in Germany. This ambitious project involves constructing a 100-megawatt proton-exchange membrane (PEM) hydrogen electrolyser at the Shell Energy and Chemicals Park Rheinland. Scheduled to commence operations in 2027, […]
In a landmark development for renewable energy in Greece, the Enipeas solar project has officially commenced, spearheaded by a partnership between Ameresco Sunel Energy SA and Lightsource bp. This ambitious project, one of the largest solar energy initiatives in Europe, underscores Greece’s commitment to advancing sustainable energy solutions and boosting economic resilience. Enipeas Solar Project: […]
Abu Dhabi Future Energy Company PJSC – Masdar has made headlines with its latest announcement, marking a significant advancement in the renewable energy sector. The UAE’s clean energy leader revealed a groundbreaking agreement with Endesa S.A., which will see Masdar invest €817 million to acquire a substantial 49.99% stake in a portfolio of renewable energy […]
In a landmark move, the ambassadors of the European Union, under the Belgian EU presidency, officially agreed to initiate accession negotiations with Ukraine and Moldova. This significant decision was confirmed on June 14, 2024, amid the backdrop of ongoing conflicts and geopolitical tensions involving Russia. The formal clearance for starting these negotiations is anticipated to […]
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) for approval within the European Union. This recommendation is intended for the treatment of adult patients with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer, specifically those with PIK3CA, AKT1, or […]
In a stark warning, Polish Prime Minister Donald Tusk has declared that Europe is venturing into what he describes as a ‘pre-war’ era, highlighting the immediate need for the European Union (EU) to significantly enhance its defense investments. In a recent interview with a consortium of European newspapers, Tusk expressed his concerns about the current […]
In a landmark decision, the European Commission (EC) has authorized Biogen Inc.’s SKYCLARYS (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. This approval heralds SKYCLARYS as the first medication sanctioned within the European Union for this rare, genetic, and progressively debilitating neurodegenerative disease, promising a new […]
In a significant development for cervical cancer treatment, Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have announced the European Medicines Agency’s (EMA) validation for review of the marketing authorization application (MAA) for tisotumab vedotin. This antibody-drug conjugate (ADC), developed to treat adult patients with recurrent or metastatic cervical cancer who have progressed on […]
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company focused on developing life-saving therapies, announced a significant breakthrough with the United Kingdom (U.K.) Medicines and Healthcare products Regulatory Agency (MHRA) approving REZZAYO (rezafungin acetate) for invasive candidiasis treatment in adults. This announcement is a major advancement in healthcare, addressing a critical need for new treatments in […]